Published in J Trauma on August 01, 2002
Targeting iNKT cells for the treatment of sickle cell disease. Clin Immunol (2011) 1.09
Regulation of leukocyte function by adenosine receptors. Adv Pharmacol (2011) 1.04
Enduring reversal of neuropathic pain by a single intrathecal injection of adenosine 2A receptor agonists: a novel therapy for neuropathic pain. J Neurosci (2009) 1.01
Selective adenosine A2A receptor agonists and antagonists protect against spinal cord injury through peripheral and central effects. J Neuroinflammation (2011) 0.91
Receptor crosstalk: haloperidol treatment enhances A(2A) adenosine receptor functioning in a transfected cell model. Purinergic Signal (2010) 0.87
Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: a review. Life Sci (2014) 0.87
Adenosine and stroke: maximizing the therapeutic potential of adenosine as a prophylactic and acute neuroprotectant. Curr Neuropharmacol (2009) 0.82
Increases in cerebrospinal fluid caffeine concentration are associated with favorable outcome after severe traumatic brain injury in humans. J Cereb Blood Flow Metab (2007) 0.81
Adenosine A2A receptors modulate acute injury and neuroinflammation in brain ischemia. Mediators Inflamm (2014) 0.76
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med (2007) 10.00
Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med (2014) 7.23
Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med (2013) 6.21
Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature (2010) 5.05
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov (2008) 4.76
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update. Pharmacol Rev (2011) 4.16
Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation (2009) 3.75
Does the addition of glutamine to enteral feeds affect patient mortality? Crit Care Med (2005) 3.43
Blood transfusion and infection after cardiac surgery. Ann Thorac Surg (2013) 3.35
Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation. N Engl J Med (2015) 3.11
Central cannulation is safe in acute aortic dissection repair. J Thorac Cardiovasc Surg (2006) 2.98
The role of methylene blue in serotonin syndrome following cardiac transplantation: a case report and review of the literature. J Thorac Cardiovasc Surg (2012) 2.86
A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. Blood (2007) 2.69
Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation. J Exp Med (2006) 2.62
Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation. J Am Coll Cardiol (2004) 2.62
Cutting edge: Critical role for A2A adenosine receptors in the T cell-mediated regulation of colitis. J Immunol (2006) 2.37
A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells. J Immunol (2005) 2.37
Compartmentalization of neutrophils in the kidney and lung following acute ischemic kidney injury. Kidney Int (2009) 2.30
Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages. Am J Physiol Renal Physiol (2004) 2.27
Early outcomes using the Florida sleeve repair for correction of aortic insufficiency due to root aneurysms. Ann Thorac Surg (2009) 2.24
Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: the role of CD4+ T cells and IFN-gamma. J Immunol (2006) 2.22
Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow-derived cells. J Clin Invest (2003) 2.22
RIFLE criteria for acute kidney injury in aortic arch surgery. J Thorac Cardiovasc Surg (2007) 2.17
Predicted risk of mortality models: surgeons need to understand limitations of the University HealthSystem Consortium models. J Am Coll Surg (2009) 2.10
Does the Society of Thoracic Surgeons risk score accurately predict operative mortality for patients with pulmonary hypertension? J Thorac Cardiovasc Surg (2012) 2.09
Dendritic cells tolerized with adenosine A₂AR agonist attenuate acute kidney injury. J Clin Invest (2012) 2.00
2-Aminothiophene-3-carboxylates and carboxamides as adenosine A1 receptor allosteric enhancers. Bioorg Med Chem (2005) 1.94
Myocardial infarct-sparing effect of adenosine A2A receptor activation is due to its action on CD4+ T lymphocytes. Circulation (2006) 1.94
Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. Ann Thorac Surg (2002) 1.91
Practice management guidelines for the evaluation of blunt abdominal trauma: the East practice management guidelines work group. J Trauma (2002) 1.87
Alveolar macrophage activation is a key initiation signal for acute lung ischemia-reperfusion injury. Am J Physiol Lung Cell Mol Physiol (2006) 1.80
The use of polynomial neural networks for mortality prediction in uncontrolled venous and arterial hemorrhage. J Trauma (2002) 1.79
Infarct-sparing effect of A2A-adenosine receptor activation is due primarily to its action on lymphocytes. Circulation (2005) 1.75
Intrathoracic vacuum-assisted management of persistent and infected pleural spaces. Ann Thorac Surg (2010) 1.74
Ex vivo rehabilitation of non-heart-beating donor lungs in preclinical porcine model: delayed perfusion results in superior lung function. J Thorac Cardiovasc Surg (2012) 1.73
NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-gamma and CXCR3 chemokines. Blood (2009) 1.69
Primary payer status affects mortality for major surgical operations. Ann Surg (2010) 1.69
Activation of A2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease. Gastroenterology (2005) 1.66
Do you need to clamp a patent left internal thoracic artery-left anterior descending graft in reoperative cardiac surgery? Ann Thorac Surg (2009) 1.63
Therapeutic anti-inflammatory effects of myeloid cell adenosine receptor A2a stimulation in lipopolysaccharide-induced lung injury. J Immunol (2007) 1.62
Lipopolysaccharide rapidly modifies adenosine receptor transcripts in murine and human macrophages: role of NF-kappaB in A(2A) adenosine receptor induction. Biochem J (2005) 1.60
Extracellular adenosine regulates naive T cell development and peripheral maintenance. J Exp Med (2013) 1.57
Adenosine A2A receptors induced on iNKT and NK cells reduce pulmonary inflammation and injury in mice with sickle cell disease. Blood (2010) 1.56
Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction. Am J Physiol Gastrointest Liver Physiol (2004) 1.55
Cost-analysis of percutaneous pulmonary valve implantation compared to surgical pulmonary valve replacement. Catheter Cardiovasc Interv (2013) 1.53
Smooth muscle phenotypic modulation is an early event in aortic aneurysms. J Thorac Cardiovasc Surg (2009) 1.53
Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy. Am J Physiol Renal Physiol (2005) 1.52
High spatial resolution magnetic resonance imaging of cystic adventitial disease of the popliteal artery. J Vasc Surg (2010) 1.52
Is mitral valve repair superior to replacement in elderly patients? Ann Thorac Surg (2008) 1.52
Percutaneous intentional extraluminal recanalization in patients with chronic critical limb ischemia. Radiology (2004) 1.51
Sleep deprivation does not affect operative results in cardiac surgery. Ann Thorac Surg (2004) 1.51
Blood transfusions correlate with infections in trauma patients in a dose-dependent manner. Am Surg (2002) 1.50
NF-κB is activated in CD4+ iNKT cells by sickle cell disease and mediates rapid induction of adenosine A2A receptors. PLoS One (2013) 1.50
Improved resuscitation minimizes respiratory dysfunction and blunts interleukin-6 and nuclear factor-kappa B activation after traumatic hemorrhage. Crit Care Med (2002) 1.50
Coronary artery bypass with ventricular restoration is superior to coronary artery bypass alone in patients with ischemic cardiomyopathy. J Thorac Cardiovasc Surg (2004) 1.50
A2B adenosine receptor gene deletion attenuates murine colitis. Gastroenterology (2008) 1.49
Proinflammatory response of alveolar epithelial cells is enhanced by alveolar macrophage-produced TNF-alpha during pulmonary ischemia-reperfusion injury. Am J Physiol Lung Cell Mol Physiol (2007) 1.48
Is off-pump coronary artery bypass grafting superior to conventional bypass in octogenarians? J Thorac Cardiovasc Surg (2010) 1.47
Blood product conservation is associated with improved outcomes and reduced costs after cardiac surgery. J Thorac Cardiovasc Surg (2013) 1.45
Comparison of systemic and retrograde delivery of adenosine A2A agonist for attenuation of spinal cord injury after thoracic aortic cross-clamping. Ann Thorac Surg (2006) 1.44
Additive protection against lung ischemia-reperfusion injury by adenosine A2A receptor activation before procurement and during reperfusion. J Thorac Cardiovasc Surg (2007) 1.42
Replacement of the proximal aorta adds no further risk to aortic valve procedures. Ann Thorac Surg (2007) 1.40
Mitral stenosis caused by an amplatzer occluder device used to treat a paravalvular leak. Ann Thorac Surg (2012) 1.39
The A2B adenosine receptor impairs the maturation and immunogenicity of dendritic cells. J Immunol (2009) 1.39
Human A(2A) adenosine receptors: high-affinity agonist binding to receptor-G protein complexes containing Gbeta(4). Mol Pharmacol (2002) 1.39
Caring for the residents: the view of two program directors. Ann Thorac Surg (2004) 1.38
Addressing the paucity of underrepresented minorities in academic surgery: can the "Rooney Rule" be applied to academic surgery? Am J Surg (2010) 1.38
Surgical ventricular restoration: the RESTORE Group experience. Heart Fail Rev (2004) 1.37
A novel neutrophil-specific PET imaging agent: cFLFLFK-PEG-64Cu. J Nucl Med (2009) 1.36
Natural killer T cell-derived IL-17 mediates lung ischemia-reperfusion injury. Am J Respir Crit Care Med (2011) 1.35
Activation of adenosine 2A receptors attenuates allograft rejection and alloantigen recognition. J Immunol (2007) 1.32
A2A adenosine receptor activation improves survival in mouse models of endotoxemia and sepsis. J Infect Dis (2004) 1.32
Adenosine A2A agonists in development for the treatment of inflammation. Expert Opin Investig Drugs (2005) 1.31
Anatomy of adenosine A2A receptors in brain: morphological substrates for integration of striatal function. Neurology (2003) 1.31
A2A adenosine receptors on bone marrow-derived cells protect liver from ischemia-reperfusion injury. J Immunol (2005) 1.30
Adenosine A2B receptor blockade slows growth of bladder and breast tumors. J Immunol (2011) 1.28